Latha Pathangey

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine

Vani Lakshminarayanan, Pamela Thompson, Margreet A. Wolfert et al. · Proceedings of the National Academy of Sciences · 2011 · 300 citations · Full text

Life Sciences, Immunology, Oncology +17

Reduced T-Cell and Dendritic Cell Function Is Related to Cyclooxygenase-2 Overexpression and Prostaglandin E2 Secretion in Patients With Breast Cancer

Barbara A. Pockaj, Gargi D. Basu, Latha Pathangey et al. · Annals of Surgical Oncology · 2004 · 168 citations

Life Sciences, Immunology, Oncology +13

Cyclooxygenase-2 Inhibitor Induces Apoptosis in Breast Cancer Cells in an <i>In vivo</i> Model of Spontaneous Metastatic Breast Cancer

Gargi D. Basu, Latha Pathangey, Teresa L. Tinder et al. · Molecular Cancer Research · 2004 · 151 citations · Full text

Medicine, Oncology, Pharmacology +16

Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells

Gargi D. Basu, Latha Pathangey, Teresa L. Tinder et al. · Breast Cancer Research · 2005 · 142 citations · Full text

Medicine, Oncology, Pharmacology +16

MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model

Pinku Mukherjee, Latha Pathangey, Jillian Bradley et al. · Vaccine · 2006 · 82 citations · Full text

Medicine, Immunology, Oncology +16